Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Deproteinized serum

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Deproteinized serum

EINECS N/A
CAS No. 68070-90-6 Density N/A
PSA N/A LogP N/A
Solubility N/A Melting Point N/A
Formula N/A Boiling Point N/A
Molecular Weight 0 Flash Point N/A
Transport Information N/A Appearance N/A
Safety Poison by intravenous route. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Experimental reproductive effects. Risk Codes N/A
Molecular Structure Molecular Structure of 68070-90-6 (Blood, exts.) Hazard Symbols N/A
Synonyms

N/A

 

Deproteinized serum Chemical Properties

An extract from calf blood containing inorganic salts, amino acids, polypeptides and purines, but no proteins nor antigenic substances or blood group characteristics. Its exact composition is unknown. It has been proposed as a radiation-protective agent.
Product Name: Deproteinized serum
Synonyms of Deproteinized serum (CAS NO.68070-90-6): Blood, exts

Deproteinized serum Uses

 Deproteinized serum (CAS NO.68070-90-6) is often used as a rapid method for analysis of drugs and small molecules in serum in HPLC.

Deproteinized serum Toxicity Data With Reference

1.    

orl-rat LD50:1200 mg/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.
2.    

scu-rat LD50:800 mg/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.
3.    

ivn-rat LD50:400 mg/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.
4.    

orl-mus LD50:4 g/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.
5.    

scu-mus LD50:2 g/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.
6.    

ivn-mus LD50:2 g/kg

    KSRNAM    Kiso to Rinsho. Clinical Report. 7 (1973),2298.

Deproteinized serum Safety Profile

Poison by intravenous route. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Experimental reproductive effects.

Deproteinized serum Specification

Reversed-phase liquid chromatography was investigated for the determination of anticonvulsants by direct injection of deproteinized serum (CAS NO.68070-90-6). Octyl modified silica (RP-8) as stationary phase and phosphate buffer (0.1M pH=3.0) — butanol 92∶8 (v/v) as mobile phase was found suitable for the simultaneous determination of primidone, phenobarbital, carbamazepine and diphenyl hydantoine directly in deproteinized sera from patients. Anticonvulsants like sulthiam, phenyl ethyl malondiamide, ethyl methyl succinimide and the epoxide metabolite of carbamazepine cannot be determined in this way because of disturbance by the serum background. It is shown that the analytical column can be used for on-column concentration of anticonvulsants with 1 cm3 deproteinized serum. The technique proved to be suitable for the determination of phenytoine-3-norvaline in serum.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 68070-90-6